Abstract
Pain is the main symptom in cancer patients that needs to be addressed immediately because it can reduce the quality of life. Concern or the ineffectiveness of using one type of opioid makes it necessary for clinicians to understand how to rotate opioids. Therefore, this evidence-based case report was conducted to identify the effectiveness of opioid rotation and combined opioids for the cancer pain management through a literature search on three databases. Literature searching was performed by using Pubmed, Cochrane library, and EBSCO according to clinical inquiries. Of the 24 studies obtained, only one study met the criteria and was then critically assessed. The study found that pain score in both opioid rotation group (fentanyl transdermal) and combined opioids group (oral oxycodone and fentanyl transdermal) was decreased from 2.9 to 2.0 (p=0.22) and 3.0 to 1.8 (p<0.06), respectively. In addition, therapeutic success was achieved in 11 patients in the opioid rotation group and 12 patients in the combined opioids group (p=0.98). Based on the study, it can be concluded that opioid rotation is as effective as combined opioids in managing pain in cancer patients.
References
1. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit, Kementerian Kesehatan RI. Penyakit kanker di Indonesia berada pada urutan 8 di Asia Tenggara dan urutan 23 di Asia. Jakarta: P2P Kemenkes RI; 2019.2. Dima D, Tomuleasa C, Frinc I, Pasca S, Magdo L, Berindan-Neagoe I, et al. The use of rotation to fentanyl in cancer-related pain. J Pain Res. 2017;10:341–8. 3. Jack B, Chapman L. Cancer pain assessment and management. Br J Cancer. 2004;91(3):605. 4. Merskey H BN. Descriptions of chronic pain syndromes and definitions of pain terms. Washington, D.C: IASP Press; 1994. 5. van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–49. 6. te Boveldt N, Vernooij-Dassen M, Burger N, Ijsseldijk M, Vissers K, Engels Y. Pain and its interference with daily activities in medical oncology outpatients. Pain Physician. 2013;16(4):379–89. 7. World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018.8. Sarzi-Puttini P, Vellucci R, Zuccaro SM, Cherubino P, Labianca R, Fornasari D. The appropriate treatment of chronic pain. Clin Drug Investig. 2012;32(suppl 1):21–33. 9. Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, et al. Adult cancer pain, version 3. J Natl Compr Cancer Netw. 2019;17(8):977–1007. 10. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93(3):247–57. 11. King S, Forbes K, Hanks GW, Ferro CJ, Chambers EJ. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: A European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011;25(5):525–52. 12. Abu-odah H, Molassiotis A, Liu J. Challenges on the provision of palliative care for patients with cancer in low- and middle-income countries : a systematic review of reviews. BMC Palliat Care. 2020;19(55):1–16. 13. McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, et al. Safe and Appropriate Use of Methadone in Hospice and Palliative Care: Expert Consensus White Paper. J Pain Symptom Manage. 2019;57(3):e4.14. Hino C, Ran-Castillo D, Akhtari M, Cao H, Silvestre J. Role of ketamine and opioid rotation in the management of opioid induced hyperalgesia in a patient with acute promyelocytic leukemia. J Oncol Pharm Pract. 2022; 2022:10781552221074285.15. Kvolik S, Koruga N, Skiljic S. Analgesia in the neurosurgical intensive care unit. Front Neurol. 2022;12:1–8. 16. Fine PG, Portenoy RK. Establishing “best practices” for opioid rotation : conclusions of an expert panel. J Pain Symptom Manage. 2009;38(3):418–25. 17. Mercadante S. Opioid combination: rationale and possible clinical applications. Opioid Comb Ration possible Clin Appl. 2013;2(4):189–96. 18. Morita T, Tei Y, Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration Title. J Palliat Med. 2003;4:557–63. 19. Connor SR, Bermedo MCS, Baxter S, Beckwith SK, Clark D, Cleary J, et al. Global atlas of palliative care at the end of life. Geneva: World Health Organization; 2014. 20. Seya MJ, Gelders SFAM, Achara OU, Milani B, Scholten WK. A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels. J Pain Palliat Care Pharmacother. 2011;25(1):6–18. 21. Kim HJ, Kim YS, Park SH. Opioid rotation versus combination for cancer patients with chronic uncontrolled pain: A randomized study. BMC Palliat Care. 2015;14(1):1–6. 22. Knotkova H, Fine PG, Portenoy RK. Opioid Rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage. 2009;38(3):426–39. 23. Indelicato RA, Portenoy RK. Opioid rotation in the management of refractory cancer pain. 2002;20(1):348–52. 24. Häuser W, Bock F, Engeser P, Tölle T, Willweber-Strumpfe A, Petzke F. Long-term opioid use in non-cancer pain. Dtsch Arztebl Int. 2014;111(43):732–40. 25. Quigley C, Vora RR. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev. 2004;3:CD004847.26. Schellekens AFA, Veldman SE, Suranto ESD, van Rijswijk SM, van der Wal SEI, Schene AH, et al. Beneficial effects of opioid rotation to buprenorphine/naloxone on opioid misuse, craving, mental health, and pain control in chronic non-cancer pain patients with opioid use disorder. J Clin Med. 2021;10(16):1–13. 27. Smith M. Differences between and combinations of opioids re-visited. Curr Opin Anaesthesiol. 2008;5:596–601. 28. Shinjo T, Okada M. The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report. Gan To Kagaku Ryoho. 2005;32(12):1997–2000. 29. Marinangeli F, Aloisio L. Improved cancer pain treatment using combined fentanyl-TTS and tramadol. Pain Pr. 2007;7:307–12. 30. Babu KM, Brent J, Juurlink DN. Prevention of opioid overdose. N Engl J Med. 2019;380(23):2246–55. 31. Treillet E, Laurent S, Hadjiat Y. Practical management of opioid rotation and equianalgesia. J Pain Res. 2018;11:2587–601. 32. Morriss WW, Roques CJ. Pain management in low- and middle-income countries. BJA Educ. 2018;18(9):265–70.
Recommended Citation
Faisal, Edward; Puspadina, Shafira; Puranto, Rudi; and Shatri, Hamzah
(2022)
"Effectivity of Opioid Rotation Compared to Opioid Combination for Cancer Pain: An Evidence Case Report,"
Jurnal Penyakit Dalam Indonesia: Vol. 9:
Iss.
2, Article 7.
DOI: 10.7454/jpdi.v9i2.736
Available at:
https://scholarhub.ui.ac.id/jpdi/vol9/iss2/7